Interestingly, the APOE ε4 allele frequency is similar between pure PSP patients with minimal or no Alzheimer-type pathology (11%) and controls, whereas it is significantly higher in PSP patients with concomitant Alzheimer-type pathology (64%) or with pathologic aging (38%). Here, APOE is linked to supranuclear palsy, progressive, 1.